Publicacions en col·laboració amb investigadors/es de Hospital Universitario Marqués de Valdecilla (37)

2023

  1. Testing a vaccine candidate against Hepatitis C virus designed by combinatorial optimization

    Scientific Reports, Vol. 13, Núm. 1

2022

  1. First computational design using lambda-superstrings and in vivo validation of SARS-CoV-2 vaccine

    Scientific Reports, Vol. 12, Núm. 1

  2. Gold Glyconanoparticles Combined with 91–99 Peptide of the Bacterial Toxin, Listeriolysin O, Are Efficient Immunotherapies in Experimental Bladder Tumors

    Cancers, Vol. 14, Núm. 10

2021

  1. A Comparison Between Recombinant Listeria GAPDH Proteins and GAPDH Encoding mRNA Conjugated to Lipids as Cross-Reactive Vaccines for Listeria, Mycobacterium, and Streptococcus

    Frontiers in Immunology, Vol. 12

  2. Glyceraldehyde-3-phosphate dehydrogenase common peptides of listeria monocytogenes, mycobacterium marinum and streptococcus pneumoniae as universal vaccines

    Vaccines, Vol. 9, Núm. 3

2020

  1. Epitopes for Multivalent Vaccines Against Listeria, Mycobacterium and Streptococcus spp: A Novel Role for Glyceraldehyde-3-Phosphate Dehydrogenase

    Frontiers in Cellular and Infection Microbiology, Vol. 10

2019

  1. Pre-clinical development of Listeria-based nanovaccines as immunotherapies for solid tumours: insights from melanoma

    OncoImmunology, Vol. 8, Núm. 2

2017

  1. Dendritic cell therapy in melanoma

    Annals of Translational Medicine, Vol. 5, Núm. 19, pp. 1-9

  2. GNP-GAPDH1-22 nanovaccines prevent neonatal listeriosis by blocking microglial apoptosis and bacterial dissemination

    Oncotarget, Vol. 8, Núm. 33, pp. 53916-53934

  3. Gold glyconanoparticles coupled to listeriolysin O 91-99 peptide serve as adjuvant therapy against melanoma

    Nanoscale, Vol. 9, Núm. 30, pp. 10721-10732

  4. Report from the II Melanoma Translational Meeting of the Spanish Melanoma Group (GEM)

    Annals of Translational Medicine, Vol. 5, Núm. 19

2016

  1. Biomarker tools to design clinical vaccines determined from a study of annual listeriosis incidence in northern Spain

    Frontiers in Immunology, Vol. 7, Núm. NOV

  2. Exceptional antineoplastic activity of a dendritic-cell-targeted vaccine loaded with a Listeria peptide proposed against metastatic melanoma

    Oncotarget, Vol. 7, Núm. 13, pp. 16855-16865

  3. Pregnancy vaccination with gold glyco-nanoparticles carrying Listeria monocytogenes peptides protects against listeriosis and brain- and cutaneous-associated morbidities

    Nanomaterials, Vol. 6, Núm. 8

2015

  1. A gold glyco-nanoparticle carrying a listeriolysin O peptide and formulated with Advax™ delta inulin adjuvant induces robust T-cell protection against listeria infection

    Vaccine, Vol. 33, Núm. 12, pp. 1465-1473

  2. A novel therapy for melanoma developed in Mice: Transformation of melanoma into dendritic cells with Listeria monocytogenes

    PLoS ONE, Vol. 10, Núm. 3

  3. Clinical and genetic features of Spanish patients with Mevalonate kinase deficiency

    Pediatric Rheumatology, Vol. 13, Núm. 1

  4. Epidemiología y datos clínicos de la infección por el virus respiratorio sincitial en niños mayores de 2 años hospitalizados. Estudio multicéntrico nacional (FIVE)

    Acta Pediatrica Espanola, Vol. 73, Núm. 1, pp. 5-9

  5. Identification and characterisation of T-cell epitopes for incorporation into dendritic cell-delivered Listeria vaccines

    Journal of Immunological Methods, Vol. 424, pp. 111-119

  6. Novel nanoparticle vaccines for listeriosis

    Human Vaccines and Immunotherapeutics, Vol. 11, Núm. 10, pp. 2501-2503